Anixa Biosciences Inc.

ANIX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.71

+$0.01 (+0.37%)

Sep 22, 2026, 1:11 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $91.86M

Enterprise Value $78.17M

Beta 0.60

Average Volume 224.8K

Shares Outstanding (Diluted) 34.18M

Shares Change YoY 5.25%

Institutional Ownership 15.20%

Exchange NASDAQ

ISIN US03528H1095

Price Performance

Price Change 1M -26.8%

Price Change 3M -2.2%

Price Change 6M 0.0%

Price Change YTD -14.6%

Price Change 1Y -22.6%

Price Change 3Y -19.4%

Price Change 5Y -44.8%

1M CAGR (ann.) -21.1%

1Y CAGR (ann.) -19.9%

5Y CAGR (ann.) -11.5%

All-Time CAGR -7.8%

Valuation

PE Ratio -9.00

Forward PE N/A

PEG Ratio 0.01

Forward PEG -5.55

PS Ratio N/A

Forward PS 2.70

PB Ratio 6.35

P/FCF Ratio -12.45

P/Adj. FCF Ratio -9.75

P/OCF Ratio -12.27

EV/Sales N/A

EV/EBIT -7.39

EV/EBITDA -7.40

EV/FCF -10.60

Earnings Yield -11.1%

FCF Yield -8.0%

Adj. FCF Yield -10.3%

Financial Health

Net Cash $13.69M

Total Debt $174K

Cash & Short-Term Investments $13.86M

Total Assets $15.07M

Current Ratio 8.54

Quick Ratio 8.54

Debt / Equity Ratio 0.01

Debt / EBITDA -0.02

Debt / FCF -0.02

OCF / Debt -42.39

Interest Coverage 0.00

Altman Z-Score 4.07

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -27.7%

Returns

Return on Assets -69.1%

Return on Equity -70.4%

Return on Invested Capital -82.1%

Return on Capital Employed -82.3%

Return on Tangible Assets -69.1%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y -50.0%

Revenue CAGR 10Y -32.0%

EPS CAGR 3Y 18.9%

EPS CAGR 5Y 24.9%

EPS CAGR 10Y 11.3%

FCF CAGR 3Y 13.8%

FCF CAGR 5Y -5.5%

FCF CAGR 10Y -7.8%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 6

EPS Growth Next 3Y -8.9%

Revenue Growth Next 3Y N/A

Earnings Date Jan 10, 2027

EPS Estimate (next Q) -$0.08

EPS Growth Est (next Q) -11.1%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $5.83

Price Target Upside 115.9%

Cash Flow

Operating Cash Flow $-7.38M

Free Cash Flow $-7.38M

Adj. Free Cash Flow $-9.42M

FCF Per Share -$0.22

OCF Per Share -$0.22

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-19K

Operating Income $-10.98M

EBITDA $-10.56M

Net Income $-10.42M

EPS (Diluted) -$0.30

Revenue / Employee N/A

Profit / Employee $-2.61M

Employees 4